ince the first successful valve replacement using the original Starr-Edwards (S-E) caged silastic ball valve, some engineering modifications were made to enhance hemodynamic performance and fixation. The fabric covering was extended to the inflow orifice and then to the cage, and a silastic ball was changed to a stellite ball, which resulted in a group of "cloth-covered S-E ball valves". 1,2 Between June 1968 and March 1977, the clothcovered ball valves were used for aortic and mitral valve replacement (MVR) on a routine basis. Long-term results with the S-E ball valves have been reported showing satisfactory results with reliable durability and safety; they could represent the standard in mechanical valve replacement until recent prostheses can show a significant improvement in long-term results. However, reoperation after valve replacement with the S-E ball valve is unavoidable, and there have been only a few articles reporting detailed data concerning reoperations for the cloth-covered model of the S-E ball valve. The present study reports valve dysfunction and reoperation for the cloth-covered S-E ball prostheses.
ince the first successful valve replacement using the original Starr-Edwards (S-E) caged silastic ball valve, some engineering modifications were made to enhance hemodynamic performance and fixation. The fabric covering was extended to the inflow orifice and then to the cage, and a silastic ball was changed to a stellite ball, which resulted in a group of "cloth-covered S-E ball valves". 1, 2 Between June 1968 and March 1977, the clothcovered ball valves were used for aortic and mitral valve replacement (MVR) on a routine basis. Long-term results with the S-E ball valves have been reported showing satisfactory results with reliable durability and safety; they could represent the standard in mechanical valve replacement until recent prostheses can show a significant improvement in long-term results. However, reoperation after valve replacement with the S-E ball valve is unavoidable, and there have been only a few articles reporting detailed data concerning reoperations for the cloth-covered model of the S-E ball valve. The present study reports valve dysfunction and reoperation for the cloth-covered S-E ball prostheses.
Methods

Patients
The cloth-covered S-E ball valves (aortic model 2300, 2310, 2320, and 2400, and mitral model 6300, 6310, 6320, and 6400) were implanted in the aortic and/or mitral position as the first choice for prosthetic substitution at our institution between June 1968 and March 1977. Oral anticoagulation regimens were administered after surgery and left at our outpatient clinic or local general practitioner's clinic. Among the 66 operative survivors who underwent an isolated aortic valve replacement (AVR; n=14) or MVR (n=52), 20 patients (11 male and 9 female) required reoperation 22 times because of valve dysfunction, thromboembolic complication, paravalvular leakage, hemolytic anemia, and/or prosthetic valve endocarditis. Reoperation was carried out at a mean of 15.9±9.8 years (range, 2.3 to 34.2 years) after initial valve replacement. The S-E valves were re-implanted 8 times in the aortic position (n=7; group A) and 14 times in the mitral position (n=13; group M) at a mean age of 44.7±13.9 years (range, 14 to 66 years). The S-E valves used at the initial operations and indications for reoperation are listed in Table 1 . At reoperation, the heart was completely mobilized through a repeat median sternotomy and cardiopulmonary bypass was implemented through the femoral artery or the aorta for arterial perfusion, and right atrium for venous drainage. The patient's systemic temperature was cooled to 32°C and the heart was arrested using St Thomas' cold crystalloid cardioplegic solution. Care was taken during the prosthesis excision not to remove any structures from the prosthetic surfaces to avoid artificial changes on the prosthesis. The prosthetic valve was replaced using an interrupted method with braided polyester sutures or pledgeted polyester sutures at the supra-annular position.
Excised valves were carefully examined, and morbidity after the initial and subsequent operations was defined according to the guidelines for reporting morbidity and mortality after cardiac valvular operations, as published by Edmunds et al. 3 Cloth wear was presented as follows: (+) slight cloth wear at struts and/or orifice; (++) moderate cloth wear at struts and/or orifice; and (+++) cloth tear at orifice and/or cloth dislodgement at struts. Pannus formation was presented as follows: (+) pannus formation at sewing ring; (++) pannus formation at sewing ring and struts; and (+++) pannus overgrowth at studs. Continuous data were presented as mean ± SD; chisquare tests were performed to compare and to check the differences between patient groups A and M for significance. Reoperation-free curves were obtained by using the Kaplan-Meier method and were compared using the log-rank test. Statistical analysis was carried out using StatView software version 5.0 (SAS Institute, Inc, NC, USA).
Results
Reoperations were performed in a total of 20 patients (30.3% of the operative survivors). One group A patient and 1 group M patient underwent reoperation with the S-E cloth-covered model for paravalvular leakage and pannus stenosis respectively. Structural valve dysfunction was found in all 20 patients 21 times excluding 1 group A patient who underwent reoperation for paravalvular leakage. The reasons of reoperation were valve dysfunction (9 patients), thromboembolism (7 patients), paravalvular leakage (2 patients), prosthetic endocarditis (1 patient), hemolytic anemia (1 patient), and pannus stenosis (1 patient) ( Table 1) .
Operative Mortality at Reoperation
Reoperations were performed in 7 patients (50% of the patient population) with AVR and in 13 patients (25% of the patient population) with MVR. A significant difference in the rate of reoperation between group A and group M was not found. In the aortic position, patient 1 died on the first postoperative day after a second AVR operation with model 2320 because of bleeding and operative mortality after redo AVR was 14.2%. In the mitral position, patient 2 died because of low output syndrome after redo MVR operation with model 6320, and operative mortality after redo MVR was 7.6%. Overall 30-day mortality for both redo AVR and redo MVR was 10.0%.
Freedom From Reoperation
Freedom from reoperation for AVR and MVR was 56.2% at 34 years and 61.0% at 37 years, respectively (Fig 1) . The standard error for all Kaplan-Meier percentages was 5%. Freedom from reoperation between 2 groups was not significant, and overall actuarial freedom from reoperation was 89.9% at 10 years, 78.3% at 20 years, 73.3% at 30 years, and 59.5% at 37 years (Fig 2) .
Thromboembolic Events
Thromboembolic events including valve thrombosis and/or embolism were observed in 40% of the patients who required reoperation. The incidence rate of thromboembolism was 28.6% (2/7) in group A and 38.5% (5/13) in group M. A significant difference in the incidence rate of thromboembolism was not found between group A and group M.
Concomitant Valve Procedures
Concomitant valve procedures at reoperation are listed in Table 2 , and reoperations were required mainly for valve-related complications and/or other aggravated valve lesions. Abnormal prosthetic regurgitation was more frequently observed in the mitral position than in the aortic position. More complicated procedures were required in patients who underwent valve replacement in the mitral position. 
Excised Valve Findings
Cloth wear/tear or pannus formation were observed in all prostheses, as shown in Table 2 . As postoperative time passed, degradation was more markedly extended in the prostheses than expected. The cloth inside the valve struts was worn through and the cage metal exposed, while remnant cloth surrounding the outside was detached from struts and loosened. Orifice cloth was more markedly worn in the mitral valves than in aortic valves, and tear was usually observed in valves that were more than 20 years old (Fig 3) . Also, pannus overgrowth over the studs around the orifice area was observed resulting in regurgitation through the valve orifice in the valves (Figs 4,5) . Pannus overgrowth was marked at the struts area close to the orifice Pannus overgrowth was observed behind the struts at the valve orifice, and the cloth was completely worn around the valve orifice area. Excised valve showed severe pannus formation over the studs on the strut orifice (Right). Significant cloth wear and dislodgement were observed inside the struts and orifice presenting bare metal struts and orifice. The stellite ball could not touch the studs around the orifice because of pannus overgrowth. Fig 3. Intraoperative view of the 27.5 year-aged aortic valve (model 2400) in patient 1 (Left). Cloth wear was observed around the valve orifice area and pannus overgrowth around the orifice, markedly at the strut area. Excised valve showed severe pannus formation over the studs around the orifice (Right). Dislodgement of the cloth on the struts was slightly observed in this 'track' model. The stellite ball could not touch the studs around the orifice because of pannus overgrowth. Pannus overgrowth and thrombus formation were observed behind the struts at the valve orifice, and the cloth was completely worn around the valve orifice area, presenting bare metal orifice. The excised valve showed severe pannus and thrombus formation over the valve orifice, especially at the strut area (Right). The stellite ball could not touch the studs around the orifice because of pannus overgrowth.
where the struts arose. The stellite ball could not touch the studs around the orifice because of pannus overgrowth. Pannus inside the orifice contributed to valve dysfunction through insufficient valve closing. These findings, such as severe cloth wear/tear and pannus overgrowth in the orifice area, contributed to thromboembolic complications and hemodynamic deterioration, especially in patients who underwent valve replacement more than 20 years ago.
Discussion
Since the first successful valve replacement using the original S-E caged silastic ball valve, implantations of S-E valves, which experienced several modifications, exceed 200,000 cases and long-term results with this valve have been reported showing satisfactory results with reliable durability and safety. 1, 2, 4 The cloth-covered model of the S-E stellite-ball valve was introduced to eliminate the larger metal surface and ball variance in the original silastic ball prosthesis, with the intention of reducing thromboembolism. The fabric extension was extended from the inflow orifice to the cage (model 2300 and model 6300), and composite seat prosthesis (model 2310 and model 6310), which featured small metallic studs around the orifice was introduced, resulting in the protection of the orifice cloth on valve closure. Subsequent models (model 2320 and 6320) were introduced in which the valve cage tapered toward the orifice so that the ball was situated on the composite seat along the centerline of the cage. Then the final ball valves, called 'track valves' (model 2400 and model 6400), were introduced and had a bare stellite track inside each strut so that the poppet touched only the metal track and studs, protecting struts and orifice cloth from ball wear and tear. 5 However, the initially observed improvement was a function of the time frame of implantation and the cloth covering offered no overall advantage with regard to reduced thromboembolism. 6 Later, these cloth-covered models were discontinued in favor of the original bare strut design, and these models became historical prostheses. However, there are still surviving patients with these valves who require strict follow-up.
Complications and morbidity after S-E ball valve replacement are thromboembolism, valve thrombosis, anticoagulant-related bleeding events, paravalvular leakage, and/or endocarditis which are the major limitations of any mechanical prostheses. Ball variance is a rare complication which occurs in early postoperative years. Tayama et al presented a case report of a patient who had an aortic S-E silastic ball valve implanted 28 years previously, demonstrating no abnormality of the explanted silastic ball, which shows that the S-E ball valve is durable in some patients. 7, 8 Cloth wear or tear is regarded as a unique problem of the cloth-covered S-E ball valve. The incidence of cloth wear in surviving patients who had a cloth-covered S-E valve replacement has been reported less than 2.6%/patient-year within 10 years' follow-up based on the results of autopsy and/or reoperation, 9,10,11 and 6% within 12 to 15 years' follow-up, 12 while actual incidence of cloth wear over 15 years has not been reported. Shah et al have indicated the following findings suggesting cloth wear: (1) transient cerebral ischemia attacks or infarction of the systemic organs despite appropriate anticoagulant therapy; (2) arterial embolism more than 4 years after valve replacement; (3) increased metal click sounds; (4) persistent severe hemolytic anemia; and (5) abnormalities in the positional relationship between the ball and the valve location at valve opening/closing under fluoroscopy, or regurgitation of contrast medium from the valve orifice. 9 They concluded that the diagnosis of cloth wear is impossible before reoperation and it was made by exclusion of other causes of recurrent transient cerebral ischemic attacks or systemic emboli and by exclusion of other causes of hemolytic anemia. Aggressive management of complications of cloth wear by reoperation is likely to prevent disabling or lethal consequences. Recently, Vermes et al evaluated the ability of transesophageal echocardiography (TEE) to detect cloth tear in 9 asymptomatic patients with a cloth-covered S-E aortic valve. An echogenic mobile structure attached to the prosthesis, suggestive of a tear, was detected in 5 patients (55%), although transthoracic echocardiography failed to detect any abnormality in all patients. Two patients had symptoms and underwent reoperation; cloth tear was more extensive than suspected by TEE. Cloth tear is a frequent finding that can be detected by TEE in asymptomatic patients with cloth-covered S-E aortic prosthesis. They recommended performing TEE and reoperation in these patients as soon as symptoms appeared. 13 In a report by Starr's group 12 among the 250 patients with model 6310/20 aortic prosthesis, 14 patients required reoperation and 10 (71%) patients were found to have strut cloth wear at reoperation; among the 171 patients with model 6310/20 mitral prosthesis, 9 patients needed reoperation and 2 patients were confirmed to have orifice cloth tear. In the aortic position, Lund et al reported a detailed follow-up for 717 patients who underwent AVR with a silastic ball valve, a cloth-covered valve or a track valve. 14 In their study, the 3 valve types did not differ with regard to long-term survival or freedom from complications, and there were no instances of structural failure apart from wear of the cloth covering the cage struts of the cloth-covered valves. Higashita et al examined a late follow-up in children with the S-E valves, focusing on the effect of valve prosthesis-patient mismatch in the growing patient. 15 Both studies concluded that the S-E ball valves were durable through the remaining lifetime of the patients and the ability to secure near normal age and sex-specific survival provided valve and patient size mismatch was avoided.
Vitale et al reviewed the pathologic and echocardiographic findings in 87 patients with mitral valve obstruction of 3 types of mechanical valves to ascertain the incidence of pannus formation and thrombosis. The frequency of pannus formation has been much higher than that of thrombus formation, but thrombosis is of earlier onset than pannus formation. Thrombosis is because of the deposition of clots on the prosthesis, and a pannus occurs because of an inflammatory reaction developing on both valve surfaces. 16 In our previous study reviewing the reoperation for cloth-covered S-E valves, there were 12 patients who required reoperation. 17 In the previous study, the mean interval at reoperation was 11.7 years, and marked cloth wear was observed in all aortic valves, but only slight wear in mitral valves. Orifice pannus formation was observed in some patients. In the present study, the mean interval at reoperation was 15.9 years and the cloth wear frequently involved the mitral position; cloth tear was frequently observed for those with more than 15 years' follow-up. The degradation process of the prosthesis would progress more markedly and frequently in the mitral position than in the aortic position because the prosthesis has been exposed to a too cruel condition of the pressure difference. Pannus over-growth inside the orifice and over the studs was frequently observed, resulting in valve dysfunction through valve regurgitation rather than stenosis. Abnormal valve regurgitation was more frequently observed in the mitral position than in the aortic position. Nowadays, most of the surviving patients who underwent a S-E ball valve replacement have survived at least 25 years after the operation. Some of them required reoperation for valve-related complications or aggravated secondary valve lesions during the follow-up period.
More complicated procedures were required in patients who underwent valve replacement in the mitral position. 1977 and 1978, 1978 and 1993, and 1993 and 2005 , respectively. After reoperation, structural dehiscence was observed in 1 patient who had the Hancock bioprosthesis and required reoperation. Two patients who underwent reoperation using the SJM bileaflet prosthesis required reoperation because of valve thrombosis in the tricuspid position. Thereafter, the Carpentier-Edwards Pericardial valve (American Edwards Laboratories, Santa Ana, CA, USA) was used for tricuspid replacement. Linealized rates of thromboembolic events at our institution of the cloth-covered S-E ball valve, SJM bileaflet prosthesis, and ATS bileaflet prosthesis were 1.29%/patient-year, 1.02%/patient-year, and 0.51%/patient-year, respectively. Thromboembolic events in the cloth-covered S-E ball valve were higher than those in the bileaflet valves. These rates of each valve type were almost similar to the previous reports. 4, 18 Valve dysfunction because of cloth wear and pannus overgrowth was more extensive than expected based on the reoperations. Clinical manifestations of heart failure, such as increasing dyspnea during exercise, edema of the extremities, disappeared after reoperation, especially in patients who underwent valve replacement more than 20 years ago. These hemodynamically deteriorated conditions could be corrected by reoperation. Aggressive management by reoperation is recommended when the cardiothoracic ratio is markedly increased on chest X-ray, and moderate prosthetic regurgitation is observed with heart failure symptoms, especially in the mitral patients. With the aortic patients, many of the surviving patients are in good condition, however, early diagnosis of these valve-related complications and decision to reoperate after strict management by chest X-ray and echocardiography are recommended as soon as symptoms appear in order to improve the long-term results for surviving patients who underwent the clothcovered S-E ball valve replacement.
